Immunogen reported $-34234000 in Operating Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbvie ABBV:US $ 4306M 135M
Acceleron Pharma XLRN:US $ -70.63M 6.97M
Agios Pharmaceuticals AGIO:US $ -89.16M 0.07M
Amgen AMGN:US $ 2378M 1550M
Arena Pharmaceuticals ARNA:US $ -194.48M 50.09M
Astellas Pharma 4503:JP Y 54079M 17989M
AstraZeneca AZN:LN -1674000000 2.8B
Bluebird Bio BLUE:US $ -216.95M 23.88M
Bristol Myers Squibb BMY:US $ 1996M 281M
Cerulean Pharma CERU:US $ -12668940 3.51M
Dicerna Pharmaceuticals DRNA:US $ -20.27M 19.97M
Eli Lilly And LLY:US $ 1476M 72.6M
Emergent Biosolutions EBS:US $ -34.7M 49.2M
Exelixis EXEL:US $ 51.62M 71.39M
Halozyme Therapeutics HALO:US $ 75.59M 17.46M
Heron Therapeutics HRTX:US $ -51.71M 8.76M
Immunogen IMGN:US $ -34.23M 6.86M
Intrexon XON:US $ -25.47M 9.8M
Karyopharm Therapeutics KPTI:US $ -43812000 5.24M
Macrogenics MGNX:US $ -52987000 12.71M
Nektar Therapeutics NKTR:US $ -113.6M 3.39M
Novartis NVS:US $ 3233M 246M
Pfizer PFE:US $ 7647M 1733M
Regeneron Pharmaceuticals REGN:US $ 1847.2M 1500M
Seattle Genetics SGEN:US $ -297.96M 208.36M